Business
BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its first quarter 2026 financial results and other key updates from the quarter.
About this update from Bausch Health Companies Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"First Quarter Consolidated Revenues of $2.52 billion, up 12% on a Reported basis and 7% on an Organic (non-GAAP)1 basis over the prior year period","length":146,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP Net Loss Attributable to Bausch Health of $1,423 million and GAAP Net Loss of $1,431 million, inclusive of a $1,426 million goodwill impairment charge","length":155,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP Loss per Share of ($3.82) (basic and diluted) compared to ($0.16) in the prior year period","length":95,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted Earnings per Diluted Share (non-GAAP) of $0.78 compared to $0.59 in the prior year period, an increase of 32%","length":118,"tagName":"p"}]},{"val":[{"type":"text","content":"Consolidated Adjusted EBITDA Attributable to Bausch Health (non-GAAP)1 of $837 million, up 27% on a Reported basis over the prior year period","length":141,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":655,"olType":false},{"type":"text","content":"BAUSCH HEALTH EXCLUDING BAUSCH + LOMB FIRST QUARTER 2026 RESULTS","length":64,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Delivered twelfth consecutive quarter of year-over-year Revenue growth and Adjusted EBITDA (non-GAAP)1 growth, with 14% Reported and 9% Organic (non-GAAP)1 Revenue growth and 17% Adjusted EBITDA (non-GAAP)1 growth","length":213,"tagName":"p"}]},{"val":[{"type":"text","content":"Generated $319 million in Adjusted Cash Flow from Operations (non-GAAP)1","length":72,"tagName":"p"}]},{"val":[{"type":"text","content":"Reaffirming full-year 2026 Revenue, Adjusted EBITDA (non-GAAP)1, and Adjusted Cash Flow from Operations (non-GAAP)1 guidance","length":124,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":409,"olType":false},{"type":"text","content":"LAVAL, QC, April 29, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its first quarter 2026 financial results and other key updates from the quarter.","length":279,"tagName":"p"},{"type":"text","content":""Our first quarter performance marks twelve consecutive periods of year‑over‑year growth in revenue, adjusted EBITDA for Bausch He...